A PARP-1 inhibitor, PJ34, inhibits Aβ-induced neuronal death in AD models, and another PARP-1 inhibitor, INO-1001, has shown neuroprotective effects in a mouse model of human Huntington’s disease [187]. Here, PARP1 is linked to juvenile Huntington disease.